Your browser doesn't support javascript.
loading
Metabolic orchestration of cell death by AMPK-mediated phosphorylation of RIPK1.
Zhang, Tao; Xu, Daichao; Trefts, Elijah; Lv, Mingming; Inuzuka, Hiroyuki; Song, Guobin; Liu, Min; Lu, Jianlin; Liu, Jianping; Chu, Chen; Wang, Min; Wang, Huibing; Meng, Huyan; Liu, Hui; Zhuang, Yuan; Xie, Xingxing; Dang, Fabin; Guan, Dongxian; Men, Yuqin; Jiang, Shuwen; Jiang, Cong; Dai, Xiaoming; Liu, Jing; Wang, Zhen; Yan, Peiqiang; Wang, Jingchao; Tu, Zhenbo; Babuta, Mrigya; Erickson, Emily; Hillis, Alissandra L; Dibble, Christian C; Asara, John M; Szabo, Gyongy; Sicinski, Piotr; Miao, Ji; Lee, Yu-Ru; Pan, Lifeng; Shaw, Reuben J; Yuan, Junying; Wei, Wenyi.
Afiliação
  • Zhang T; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
  • Xu D; Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 201203 Shanghai, China.
  • Trefts E; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
  • Lv M; The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.
  • Inuzuka H; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
  • Song G; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
  • Liu M; Division of Endocrinology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Lu J; Transfusion Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Liu J; Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
  • Chu C; Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 201203 Shanghai, China.
  • Wang M; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Wang H; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA.
  • Meng H; Department of Biliary-Pancreatic Surgery, Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030 Wuhan, Hubei, China.
  • Liu H; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
  • Zhuang Y; F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA 02115, USA.
  • Xie X; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
  • Dang F; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
  • Guan D; Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 201203 Shanghai, China.
  • Men Y; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
  • Jiang S; Division of Endocrinology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Jiang C; Division of Endocrinology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Dai X; Division of Endocrinology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Liu J; Department of Metabolic and Bariatric Surgery, The First Affiliated Hospital of Jinan University, 510632 Guangzhou, China.
  • Wang Z; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
  • Yan P; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
  • Wang J; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
  • Tu Z; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
  • Babuta M; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
  • Erickson E; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
  • Hillis AL; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
  • Dibble CC; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
  • Asara JM; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
  • Szabo G; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
  • Sicinski P; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
  • Miao J; Division of Signal Transduction, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
  • Lee YR; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
  • Pan L; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Shaw RJ; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA.
  • Yuan J; Department of Histology and Embryology, Center for Biostructure Research, Medical University of Warsaw, 02-004 Warsaw, Poland.
  • Wei W; Division of Endocrinology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Science ; 380(6652): 1372-1380, 2023 06 30.
Article em En | MEDLINE | ID: mdl-37384704
ABSTRACT
Adenosine monophosphate-activated protein kinase (AMPK) activity is stimulated to promote metabolic adaptation upon energy stress. However, sustained metabolic stress may cause cell death. The mechanisms by which AMPK dictates cell death are not fully understood. We report that metabolic stress promoted receptor-interacting protein kinase 1 (RIPK1) activation mediated by TRAIL receptors, whereas AMPK inhibited RIPK1 by phosphorylation at Ser415 to suppress energy stress-induced cell death. Inhibiting pS415-RIPK1 by Ampk deficiency or RIPK1 S415A mutation promoted RIPK1 activation. Furthermore, genetic inactivation of RIPK1 protected against ischemic injury in myeloid Ampkα1-deficient mice. Our studies reveal that AMPK phosphorylation of RIPK1 represents a crucial metabolic checkpoint, which dictates cell fate response to metabolic stress, and highlight a previously unappreciated role for the AMPK-RIPK1 axis in integrating metabolism, cell death, and inflammation.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estresse Fisiológico / Metabolismo Energético / Proteína Serina-Treonina Quinases de Interação com Receptores / Proteínas Quinases Ativadas por AMP / Necroptose Limite: Animals Idioma: En Revista: Science Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estresse Fisiológico / Metabolismo Energético / Proteína Serina-Treonina Quinases de Interação com Receptores / Proteínas Quinases Ativadas por AMP / Necroptose Limite: Animals Idioma: En Revista: Science Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos